[1] HERTL J A, SCHUKKEN Y H, WELCOME F L, et al. Effects of pathogen-specific clinical mastitis on probability of conception in Holstein dairycows[J]. J Dairy Sci, 2014, 97(11):6942-6954.
[2] HAGNESTAM-NIELSEN C, ØSTERGAARD S. Economic impact of clinical mastitis in a dairy herd assessed by stochastic simulation using different methods to model yieldlosses[J]. Animal, 2009, 3(2):315-328.
[3] POL M, RUEGG P L. Treatment practices and quantification of antimicrobial drug usage in conventional and organic dairy farms in Wisconsin[J]. J Dairy Sci, 2007, 90(1):249-261.
[4] SCHERPENZEEL C G M, HOGEVEEN H, MAAS L, et al. Economic optimization of selective dry cow treatment[J].J Dairy Sci, 2018, 101(2):1530-1539.
[5] OLDE RIEKERINK R G M, BARKEMA H W, KELTON D F, et al. Incidence rate of clinical mastitis on Canadian dairy farms[J].J Dairy Sci, 2008, 91(4):1366-1377.
[6] GAO J, BARKEMA H W, ZHANG L M, et al. Incidence of clinical mastitis and distribution of pathogens on large Chinese dairy farms[J].J Dairy Sci, 2017, 100(6):4797-4806.
[7] ROBERSON J R. Treatment of clinicalmastitis[J]. Vet Clin North Am Food Anim Pract, 2012,28(2):271-288.
[8] SUOJALA L, KAARTINEN L, PYÖRÄLÄ S. Treatment for bovine Escherichia coli mastitis-an evidence-based approach[J]. J Vet Pharmacol Ther, 2013, 36(6):521-531.
[9] LAGO A, GODDEN S M, BEY R, et al. The selective treatment of clinical mastitis based on on-farm culture results:I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes[J]. J Dairy Sci, 2011, 94(9):4441-4456.
[10] ROYSTER E, GODDEN S, GOULART D, et al. Evaluation of the Minnesota easy culturesystem Ⅱ Bi-plate and Tri-plate for identification of common mastitis pathogens in milk[J]. J Dairy Sci, 2014, 97(6):3648-3659.
[11] DOWN P M, BRADLEY A J, BREEN J E, et al. Factors affecting the cost-effectiveness of on-farm culture prior to the treatment of clinical mastitis in dairycows[J]. Prev Vet Med, 2017, 145:91-99.
[12] Office International Des Epizooties. The OIE strategy on antimicrobial resistance and the prudent use of antimicrobials[EB/OL]. (2016)[2017-07-26]. http://www.uvhvvr.gov.si/fileadmin/uvhvvr.gov.si/pageuploads/DELOVNA_PODROCJA/Zdravila/OIE-AMRstrategy.pdf.
[13] World Health Organization. Global action plan on antimicrobial resistance[EB/OL]. (2015)[2017-07-26]. http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/.
[14] KALCHAYANAND N, ARTHUR T M, BOSILEVAC J M, et al.Chromogenic agar medium for detection and isolation of Escherichia coli serogroups O26, O45, O103, O111, O121, and O145 from fresh beef and cattle feces[J]. J Food Prot, 2013, 76(2):192-199.
[15] National Mastitis Council. Guidelines on normal and abnormal raw milk based on somatic cell counts and signs of clinical mastitis[R]. Madison, U. S.:NMC Inc., 2001.
[16] DOHOO I, MARTIN W, STRYHN H. Veterinary epidemiologicresearch[M]. 2nd ed. Charlottetown:VER Inc, 2009:91-134.
[17] CYR L, FRANCIS K. Measures of clinical agreement for nominal and categorical data:the kappa coefficient[J]. Comput Biol Med, 1992, 22(4):239-246.
[18] GANDA E K, BISINOTTO R S, DECTER D H, et al. Evaluation of an on-farm culture system (Accumast) for fast identification of milk pathogens associated with clinical mastitis in dairy cows[J]. PLoS One, 2016, 11(5):e0155314.
[19] CHA E, KRISTENSEN A R, HERTL J A, et al. Optimal insemination and replacement decisions to minimize the cost of pathogen-specific clinical mastitis in dairy cows[J]. J Dairy Sci, 2014, 97(4):2101-2117.
[20] ROYSTER E, WAGNER S. Treatment of mastitis incattle[J]. Vet Clin North Am Food Anim Pract, 2015, 31(1):17-46.
[21] HERTL J A, SCHUKKEN Y H, WELCOME F L, et al. Pathogen-specific effects on milk yield in repeated clinical mastitis episodes in Holstein dairy cows[J]. J Dairy Sci, 2014, 97(3):1465-1480.
[22] OLIVEIRA L, RUEGG P L. Treatments of clinical mastitis occurring in cows on 51 largedairy herds in Wisconsin[J]. J Dairy Sci, 2014, 97(9):5426-5436.
[23] ZHANG L M, GAO J, BARKEMA H W, et al. Virulence gene profiles:alpha-hemolysin and clonal diversity in Staphylococcus aureus isolates from bovine clinical mastitis in China[J]. BMC Vet Res, 2018, 14(1):63.
[24] BOSS R, NASKOVA J, STEINER A, et al. Mastitis diagnostics:quantitative PCR for Staphylococcus aureus genotype B in bulk tank milk[J]. J Dairy Sci, 2011, 94(1):128-137.
[25] VIORA L, GRAHAM E M, MELLOR D J, et al. Evaluation of a culture-based pathogen identification kit for bacterial causes of bovine mastitis[J]. Vet Rec, 2014, 175(4):89.
[26] BOSS R, COSANDEY A, LUINI M, et al. Bovine Staphylococcus aureus:Subtyping, evolution, and zoonotic transfer[J]. J Dairy Sci, 2016, 99(1):515-528.
[27] DA COSTA L B, RAJALA-SCHULTZ P J, SCHUENEMANN G M. Management practices associated with presence of Staphylococcus aureus in bulk tank milk from Ohio dairy herds[J]. J Dairy Sci, 2016, 99(2):1364-1373.
[28] TOMAZI T, GONÇALVES J L, BARREIRO J R, et al. Bovine subclinical intramammary infection caused by coagulase-negative staphylococci increases somatic cell count but has no effect on milk yield or composition[J]. J Dairy Sci, 2015, 98(5):3071-3078.
[29] BOERLIN P, KUHNERT P, HÜSSY D, et al. Methods for identification of Staphylococcus aureus isolates in cases of bovine mastitis[J]. J Clin Microbiol, 2003, 41(2):767-771.
[30] ERSKINE R J, BARTLETT P C, VANLENTE J L, et al. Efficacy of systemic ceftiofur as a therapy for severe clinical mastitis in dairy cattle[J]. J Dairy Sci, 2002, 85(10):2571-2575. |